381 related articles for article (PubMed ID: 21103363)
1. A novel high throughput assay for anthelmintic drug screening and resistance diagnosis by real-time monitoring of parasite motility.
Smout MJ; Kotze AC; McCarthy JS; Loukas A
PLoS Negl Trop Dis; 2010 Nov; 4(11):e885. PubMed ID: 21103363
[TBL] [Abstract][Full Text] [Related]
2. Development of novel valerolactam-benzimidazole hybrids anthelmintic derivatives: Diffusion and biotransformation studies in helminth parasites.
Munguía B; Michelena M; Melian E; Saldaña J; Ures X; Manta E; Domínguez L
Exp Parasitol; 2015 Jun; 153():75-80. PubMed ID: 25816976
[TBL] [Abstract][Full Text] [Related]
3. Anthelmintic resistance detection methods.
Taylor MA; Hunt KR; Goodyear KL
Vet Parasitol; 2002 Jan; 103(3):183-94. PubMed ID: 11750111
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of anthelmintic resistance on sheep farms in New Zealand.
Waghorn TS; Leathwick DM; Rhodes AP; Lawrence KE; Jackson R; Pomroy WE; West DM; Moffat JR
N Z Vet J; 2006 Dec; 54(6):271-7. PubMed ID: 17151724
[TBL] [Abstract][Full Text] [Related]
5. Host pharmacokinetics and drug accumulation of anthelmintics within target helminth parasites of ruminants.
Lifschitz A; Lanusse C; Alvarez L
N Z Vet J; 2017 Jul; 65(4):176-184. PubMed ID: 28415922
[TBL] [Abstract][Full Text] [Related]
6. Drug resistance in human helminths: current situation and lessons from livestock.
Geerts S; Gryseels B
Clin Microbiol Rev; 2000 Apr; 13(2):207-22. PubMed ID: 10755998
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of anthelmintic resistance on sheep and goat farms in the southeastern United States.
Howell SB; Burke JM; Miller JE; Terrill TH; Valencia E; Williams MJ; Williamson LH; Zajac AM; Kaplan RM
J Am Vet Med Assoc; 2008 Dec; 233(12):1913-9. PubMed ID: 19072608
[TBL] [Abstract][Full Text] [Related]
8. Anthelmintic resistance on sheep farms in Wales.
Mitchell ES; Hunt KR; Wood R; McLean B
Vet Rec; 2010 May; 166(21):650-2. PubMed ID: 20495166
[No Abstract] [Full Text] [Related]
9. Anthelmintic resistance: past, present and future.
Sangster NC
Int J Parasitol; 1999 Jan; 29(1):115-24; discussion 137-8. PubMed ID: 10048824
[TBL] [Abstract][Full Text] [Related]
10. Managing anthelmintic resistance: is it feasible in New Zealand to delay the emergence of resistance to a new anthelmintic class?
Leathwick DM; Hosking BC; Bisset SA; McKay CH
N Z Vet J; 2009 Aug; 57(4):181-92. PubMed ID: 19649011
[TBL] [Abstract][Full Text] [Related]
11. Collaborating to tackle the problem of anthelmintic resistance.
Coles GC; Jackson F; Taylor MA; Wolstenholme AJ
Vet Rec; 2004 Aug; 155(9):253-4. PubMed ID: 15461361
[No Abstract] [Full Text] [Related]
12. Whole-organism phenotypic screening methods used in early-phase anthelmintic drug discovery.
Herath HMPD; Taki AC; Rostami A; Jabbar A; Keiser J; Geary TG; Gasser RB
Biotechnol Adv; 2022; 57():107937. PubMed ID: 35271946
[TBL] [Abstract][Full Text] [Related]
13. Zero-inflated hierarchical models for faecal egg counts to assess anthelmintic efficacy.
Wang C; Torgerson PR; Höglund J; Furrer R
Vet Parasitol; 2017 Feb; 235():20-28. PubMed ID: 28215863
[TBL] [Abstract][Full Text] [Related]
14. Managing anthelmintic resistance in small ruminant livestock of resource-poor farmers in South Africa.
Vattaa AF; Lindberg AL
J S Afr Vet Assoc; 2006 Mar; 77(1):2-8. PubMed ID: 16700468
[TBL] [Abstract][Full Text] [Related]
15. In vivo activities of the new anthelmintic depsipeptide PF 1022A.
von Samson-Himmelstjerna G; Harder A; Schnieder T; Kalbe J; Mencke N
Parasitol Res; 2000 Mar; 86(3):194-9. PubMed ID: 10726989
[TBL] [Abstract][Full Text] [Related]
16. Viability of developmental stages of Schistosoma mansoni quantified with xCELLigence worm real-time motility assay (xWORM).
Rinaldi G; Loukas A; Brindley PJ; Irelan JT; Smout MJ
Int J Parasitol Drugs Drug Resist; 2015 Dec; 5(3):141-8. PubMed ID: 26288742
[TBL] [Abstract][Full Text] [Related]
17. [Therapy and anthelmintic resistance].
Genchi C
Parassitologia; 2006 Sep; 48(3):423-31. PubMed ID: 17176955
[TBL] [Abstract][Full Text] [Related]
18. Foreword: towards markers for anthelmintic resistance in helminths of importance in animal and human health.
Prichard RK; von Samson-Himmelstjerna G; Blackhall WJ; Geary TG
Parasitology; 2007; 134(Pt 8):1073-6. PubMed ID: 17608966
[TBL] [Abstract][Full Text] [Related]
19. Minimising the development of anthelmintic resistance, and optimising the use of the novel anthelmintic monepantel, for the sustainable control of nematode parasites in Australian sheep grazing systems.
Dobson RJ; Hosking BC; Besier RB; Love S; Larsen JW; Rolfe PF; Bailey JN
Aust Vet J; 2011 May; 89(5):160-6. PubMed ID: 21495986
[TBL] [Abstract][Full Text] [Related]
20. Motility in the L3 stage is a poor phenotype for detecting and measuring resistance to avermectin/milbemycin drugs in gastrointestinal nematodes of livestock.
George MM; Lopez-Soberal L; Storey BE; Howell SB; Kaplan RM
Int J Parasitol Drugs Drug Resist; 2018 Apr; 8(1):22-30. PubMed ID: 29274827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
